FRM
IRON icon

Fox Run Management’s Disc Medicine IRON Stock Holding History

Fox Run Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$692K Buy
+10,574
New +$799K 0.08% 471

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Fox Run Management's IRON Position: Q3 2026 in Review

Fox Run Management opened a new position in Disc Medicine (IRON) in Q3 2026: 10,574 shares worth $692K. The stake represents 0.08% of the portfolio and ranks #471 among its holdings.

150 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • Fox Run Management held 10,574 shares of Disc Medicine worth $692K as of Q3 2026.
  • Disc Medicine was a new Fox Run Management position in Q3 2026.
  • Disc Medicine made up 0.08% of Fox Run Management's portfolio in Q3 2026, its #471 holding.
  • 150 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.